Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Physician
Patient
Health Care Practitioner
Pharma / Biotech Industry
Other
Topics:
Hepatology
•
Liver Diseases of Pregnancy
How do you approach fertility/family planning and counseling in patients with end-stage liver disease?
Related Questions
What management considerations do you keep in mind in the management of pregnant patients with autoimmune liver disease?
In what scenario do you continue surveillance of benign liver tumors, e.g., hepatocellular adenoma, in pregnant patients?
All things being equal, what patient factors are you looking at in the selection of TAF or TDF in the management of hepatitis B?
Do you find there is any benefit to giving N-acetyl-cysteine in non-acetaminophen related acute liver failure?
How has the move away from a strict 6 month period of sobriety impacted your patient selection criteria for transplant of patients with alcohol associated liver disease?
What kind of monitoring do you choose in patients at risk for reactivation of hepatitis B who are on immunosuppression?
How would you approach the management of drug-induced autoimmune hepatitis compared to non-drug-induced autoimmune hepatitis?
How do you explain the additional risks that a transplant recipient may carry by pursuing a hepatitis C positive organ if they are negative?
How do you utilize Cystatin-C as a marker of renal dysfunction in patients with chronic liver disease?
What is your evaluation approach for a new patient referral for an incidentally found liver lesion?
